
Last Posted: May 13, 2022
- The genetics of hereditary cancer risk syndromes in Brazil: a comprehensive analysis of 1682 patients.
de Oliveira Jarbas Maciel et al. European journal of human genetics : EJHG 2022 - Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals.
Steinberg Julia et al. Hereditary cancer in clinical practice 2022 20(1) 18 - A pragmatic implementation research study for In Our DNA SC: a protocol to identify multi-level factors that support the implementation of a population-wide genomic screening initiative in diverse populations.
Allen Caitlin G et al. Implementation science communications 2022 3(1) 48 - Increased Number Of Colorectal Interval Cancers In Lynch Syndrome After The SARS-CoV-2 Pandemic. A Survey-based Study.
Russo Michele et al. Digestive diseases (Basel, Switzerland) 2022 - Significance of rare variants in genes involved in the pathogenesis of Lynch syndrome.
Liccardo Raffaella et al. International journal of molecular medicine 2022 49(6) - The clinical features and management of Lynch syndrome-associated ovarian cancer.
Ran Xuting et al. The journal of obstetrics and gynaecology research 2022 - Utility of germline multi-gene panel testing in patients with endometrial cancer.
Karpel Hannah C et al. Gynecologic oncology 2022 - "I have always lived with the disease in the family": family adaptation to hereditary cancer-risk.
Silva Eliana et al. BMC primary care 2022 23(1) 93 - Genetic Testing for All: Overcoming Disparities in Ovarian Cancer Genetic Testing.
Frey Melissa K et al. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2022 421-12 - Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system.
Crain Philip R et al. Hereditary cancer in clinical practice 2022 20(1) 17
More
Search Result Summary
- CDC Information (8)
- NIH Information (9)
- CDC Publications (8)
- COVID-19 (5)
- Human Genome Epidemiologic Studies (265)
- GWAS Studies (0)
- Human Genomics Translation/Implementation Studies (628)
- Genomic Tests Evidence Synthesis (80)
- Genomic Tests Guidelines (41)
- Tier-Classified Guidelines (22)
- Non-Genomics Precision Health (1)
- Pathogen Advanced Molecular Detection (0)
- State Public Health Genomics Programs (78)
- Ethical/Legal and Social Issues (ELSI) (7)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2021
- Page last updated:May 16, 2022
- Content source: